Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Equity: 2021-2025

Historic Return on Equity for Biofrontera (BFRI) over the last 3 years, with Sep 2025 value amounting to 4.85%.

  • Biofrontera's Return on Equity rose 641.00% to 4.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.85%, marking a year-over-year increase of 641.00%. This contributed to the annual value of -3.85% for FY2024, which is 245.00% down from last year.
  • Biofrontera's Return on Equity amounted to 4.85% in Q3 2025, which was down 39.11% from 7.96% recorded in Q2 2025.
  • Biofrontera's 5-year Return on Equity high stood at 74.13% for Q1 2024, and its period low was -6.90% during Q4 2023.
  • Its 3-year average for Return on Equity is 7.18%, with a median of -1.56% in 2024.
  • As far as peak fluctuations go, Biofrontera's Return on Equity spiked by 7,480bps in 2024, and later crashed by 7,880bps in 2025.
  • Over the past 5 years, Biofrontera's Return on Equity (Quarterly) stood at 12.48% in 2021, then slumped by 1,251bps to -0.03% in 2022, then tumbled by 688bps to -6.90% in 2023, then skyrocketed by 334bps to -3.56% in 2024, then surged by 641bps to 4.85% in 2025.
  • Its Return on Equity was 4.85% in Q3 2025, compared to 7.96% in Q2 2025 and -4.67% in Q1 2025.